Hims & Hers Pivots to FDA-Approved Weight Loss Drugs to Settle Novo Nordisk Lawsuit
- 4 days ago
- 2 min read
The rapidly evolving market for obesity treatments experienced a major shakeup this week as telehealth platform Hims & Hers Health Inc. announced a sweeping strategic shift. In a new collaborative agreement, Hims & Hers will partner with pharmaceutical giant Novo Nordisk to expand access to branded medications, ending a contentious legal battle between the two companies.
Under the terms of the deal, Hims & Hers will soon offer its customers access to Novo Nordisk's highly sought-after Ozempic and Wegovy, including both injectable and oral forms of semaglutide. Crucially, the telehealth provider has agreed to offer these medications at Novo's self-pay prices and will completely cease advertising unapproved compounded GLP-1 drugs. Moving forward, compounded versions will only be available to a limited subset of patients if a healthcare provider determines they are clinically necessary.
The agreement immediately resolved the patent infringement lawsuit Novo Nordisk filed against Hims & Hers in February, which originally targeted the telehealth company's mass marketing of a $49 copycat Wegovy pill. Novo Nordisk has dropped the court proceedings without prejudice, though CEO Mike Doustdar noted the company reserves the right to refile if necessary.
This strategic pivot marks a significant win for federal regulators, who have been pressuring telehealth companies over unauthorized drug sales. Food and Drug Administration Commissioner Marty Makary praised the resolution on social media, expressing relief that Hims & Hers will stop advertising unapproved alternatives and instead focus on expanding affordable access to legitimate treatments.
Wall Street reacted enthusiastically to the resolution, with shares of Hims & Hers surging over 40% in morning trading following the announcement. Hims & Hers CEO Andrew Dudum highlighted that customer demand is accelerating for a broader range of branded treatments, viewing this partnership as an essential step toward building a "new model that works for everyday people".
🔖 Sources
Keywords: FDA-Approved Weight Loss Drugs
FDA-Approved Weight Loss Drugs
Comments